BOUL — Boule Diagnostics AB Share News
0.000.00%
Last trade - 00:00- SEK139.41m
- SEK342.91m
- SEK489.69m
Brief: Boule Diagnostics Receives Warning Letter From US FDA Authority
Brief: Boule Diagnostics Streamlines Production
Brief: Boule Diagnostics Q2 Operating Profit At SEK 19.8 Million
Brief: Boule Diagnostics AB Wins Order In India
Brief: Boule Diagnostics Q1 Operating Profit Rises To SEK 18.8 Million
Brief: Boule Diagnostics Unit Buys New Technologies From Drew Scientific
Brief: Boule Diagnostics Q4 Operating Profit Rises To SEK 14.9 Million
Brief: Boule Diagnostics Q3 operating profit grows to SEK 28.2 mln
Brief: Boule Diagnostics appoints christina Rubenhag new CFO
Brief: Boule Diagnostics Q2 net result swings to loss SEK 1.1 mln
Brief: Boule Diagnostics Q1 operating profit rises to SEK 12.0 mln
Brief: Boule Diagnostics wins strategic contract
Brief: Boule Diagnostics Q4 operating profit grows to SEK 1.3 mln
Brief: Boule Diagnostics Q4 operating profit up at SEK 1.3 mln
Brief: Boule Diagnostics presents new targets, adjusts dividend policy
Brief: Boule Diagnostics wins new contract in India
Brief: Tredje AP-fonden buys 7.6 pct stake in Boule Diagnostics
Brief: Boule Diagnostics names Fredrik Dalborg new CEO
Brief: Boule Diagnostics to deliver over 200 hematology systems to Egypt